HSDT (Helius Medical Technologies, Inc.) Net earnings per share (EPS TTM)

Helius Medical Technologies, Inc. (HSDT) - corporate logo

Helius Medical is scaling its proprietary neuromodulators and software across the global market. The issuer's revenues are based on the sale of PoNS systems for multiple sclerosis rehabilitation. However, a high burn rate and challenges with insurance coverage create financial risks. The annual net income per share growth rate (ttm) illustrates the rolling profit trend, where the value 99.90 reflects the current dynamics.

HSDT Helius Medical Technologies: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/15/2026

Helius Medical Technologies Inc. - analytical breakdowns and key metrics (HSDT)

- market price and analyst price targets:
Market Chart Helius Medical Technologies, Inc.|HSDT - Consensus Target
- business market valuation indicators:
Market Capitalization Helius Medical Technologies, Inc.|HSDT - Total Company Value
- shareholders' equity book value data:
Net Assets per Share Helius Medical Technologies|HSDT - Company Net Assets|Market Value to Book Value heliusmedical.com|HSDT - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Helius Medical|HSDT - Long-Term Debt to Capital|Current Liabilities to Capital heliusmedical.com|HSDT - Company Aggregate Debts|Debt to Book Value Ratio Helius Medical Technologies Inc.|HSDT - Company Long-Term Debts|Short-Term Debt Volume Helius Medical Technologies|Quick Liquidity Indicator heliusmedical.com
- business earnings and investment ratios data:
HSDT - Net Profit|Projected Future Earnings Helius Medical|HSDT - Price to Earnings Ratio|Future Price to Earnings heliusmedical.com|HSDT - PEG Multiple|Business Value to Operating Income Before Depreciation Helius Medical Technologies, Inc.|HSDT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Helius Medical Technologies|HSDT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months heliusmedical.com|HSDT - Net earnings per share growth this year|Projected earnings per share increase next year Helius Medical
- sales volume and revenue information:
HSDT - Company Revenue|Company Revenue Forecast heliusmedical.com|HSDT - P/S Multiple|Market Cap to Future Revenue Ratio Helius Medical Technologies
Fundamental company valuation:Helius Medical Technologies, Inc., HSDT
Manufactured product of Helius Medical Technologies, Inc.

Helius Medical revenues depend on the commercialization of PoNS neurotechnologies, where sales efficiency determines final profit. By analyzing the EPS YoY TTM growth trajectory, an investor assesses the rolling annual growth in earnings per share, which reveals the actual profitability trend and eliminates reporting manipulations, thereby determining the current market consensus regarding business sustainability.

Competitor analysis for Helius Medical

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE